| 摘要: |
| 目的:探讨超早产儿人型支原体感染的抗菌药物选择及药学监护。方法:临床药师参与1 例人型支原体感染超早产儿
的治疗过程,通过查阅大量文献,协助医师选择适宜患儿的抗菌药物,并给出用药监护方案。结果:患儿经抗人型支原体药物治
疗后,枕部疖肿消退;经联合其他抗菌药物治疗,体温、感染指标逐渐降至正常,未观察到药物不良反应。结论:临床药师参与特
殊患儿个体化给药方案的制定与实施,可保障药物治疗安全、有效。 |
| 关键词: 人型支原体 超早产儿 抗菌药物 药学实践 |
| DOI：doi:10.13407/j.cnki.jpp.1672-108X.2024.08.005 |
|
| 基金项目:基金项目:广西壮族自治区卫生健康委科研课题,编号Z-A20230349。 |
|
| Pharmaceutical Care for an Extremely Preterm Infant with Mycoplasma Hominis Infection by ClinicalPharmacists |
| Liu Yunyuan1, Tang Jingyi2, Tang Xiuneng1 |
| (1. Maternity and Child Health Care of Guangxi Zhuang Autonomous Region,
Nanning 530000, China; 2. Wuhan No. 1 Hospital, Wuhan 430022, China) |
| Abstract: |
| Objective: To probe into the selection of antibiotics and pharmaceutical care of Mycoplasma hominis infection in extremely
preterm infants. Methods: The clinical pharmacists participated into the treatment process of an extremely preterm infant with M.
hominis infection. By consulting a large number of literature, clinical pharmacists assisted the clinicians in selecting the appropriate
antibiotics for the infant, and provided pharmaceutical care regimen. Results: After treatment with anti-M. hominis therapy, the occipital
儿科药学杂志 2024 年第 30 卷第 8 期 ·21· Journal of Pediatric Pharmacy 2024,Vol. 30,No. 8
swelling subsided. Combined with other antibiotics for treatment, the clinical symptoms and laboratory indicators were improved, and no
adverse drug reactions were observed. Conclusion: Clinical pharmacists participate into the formulation of individualized administration
regimen for special children can ensure the safety and effectiveness of drug therapy. |
| Key words: Mycoplasma hominis extremely preterm infant antibiotics pharmacological care |
